Literature DB >> 19188439

MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes.

Sadakatsu Ikeda1, Aibin He, Sek Won Kong, Jun Lu, Rafael Bejar, Natalya Bodyak, Kyu-Ho Lee, Qing Ma, Peter M Kang, Todd R Golub, William T Pu.   

Abstract

Calcium signaling is a central regulator of cardiomyocyte growth and function. Calmodulin is a critical mediator of calcium signals. Because the amount of calmodulin within cardiomyocytes is limiting, the precise control of calmodulin expression is important for the regulation of calcium signaling. In this study, we show for the first time that calmodulin levels are regulated posttranscriptionally in heart failure. The cardiomyocyte-restricted microRNA miR-1 inhibited the translation of calmodulin-encoding mRNAs via highly conserved target sites within their 3' untranslated regions. In keeping with its effect on calmodulin expression, miR-1 downregulated calcium-calmodulin signaling through calcineurin to NFAT. miR-1 also negatively regulated the expression of Mef2a and Gata4, key transcription factors that mediate calcium-dependent changes in gene expression. Consistent with the downregulation of these hypertrophy-associated genes, miR-1 attenuated cardiomyocyte hypertrophy in cultured neonatal rat cardiomyocytes and in the intact adult heart. Our data indicate that miR-1 regulates cardiomyocyte growth responses by negatively regulating the calcium signaling components calmodulin, Mef2a, and Gata4.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188439      PMCID: PMC2663304          DOI: 10.1128/MCB.01222-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.

Authors:  Q Liang; L J De Windt; S A Witt; T R Kimball; B E Markham; J D Molkentin
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

2.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

3.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

Review 4.  The calmodulin multigene family as a unique case of genetic redundancy: multiple levels of regulation to provide spatial and temporal control of calmodulin pools?

Authors:  S L Toutenhoofd; E E Strehler
Journal:  Cell Calcium       Date:  2000-08       Impact factor: 6.817

5.  CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Authors:  R Passier; H Zeng; N Frey; F J Naya; R L Nicol; T A McKinsey; P Overbeek; J A Richardson; S R Grant; E N Olson
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  NFAT transcription factors are critical survival factors that inhibit cardiomyocyte apoptosis during phenylephrine stimulation in vitro.

Authors:  William T Pu; Qing Ma; Seigo Izumo
Journal:  Circ Res       Date:  2003-03-27       Impact factor: 17.367

7.  Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

Authors:  H W Lim; L J De Windt; J Mante; T R Kimball; S A Witt; M A Sussman; J D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2000-04       Impact factor: 5.000

8.  Gene expression profiling of the aging mouse cardiac myocytes.

Authors:  Natalya Bodyak; Peter M Kang; Makoto Hiromura; Indra Sulijoadikusumo; Nobuo Horikoshi; Konstantin Khrapko; Anny Usheva
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

9.  Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

Authors:  Chun Li Zhang; Timothy A McKinsey; Shurong Chang; Christopher L Antos; Joseph A Hill; Eric N Olson
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

10.  The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions.

Authors:  David J Simon; Jon M Madison; Annie L Conery; Katherine L Thompson-Peer; Michael Soskis; Gary B Ruvkun; Joshua M Kaplan; John K Kim
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

View more
  152 in total

1.  MicroRNAs: Novel Regulators of the Heart.

Authors:  Junjie Xiao; Yi-Han Chen
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

Review 2.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

Review 3.  Antisense MicroRNA Therapeutics in Cardiovascular Disease: Quo Vadis?

Authors:  Leonne E Philippen; Ellen Dirkx; Jan B M Wit; Koos Burggraaf; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2015-07-28       Impact factor: 11.454

Review 4.  Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction.

Authors:  Christian Schulte; Dirk Westermann; Stefan Blankenberg; Tanja Zeller
Journal:  World J Cardiol       Date:  2015-12-26

5.  NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.

Authors:  Qi Li; Xi Lin; Xiangsheng Yang; Jiang Chang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-02-19       Impact factor: 4.733

6.  A genome-wide screen reveals a role for microRNA-1 in modulating cardiac cell polarity.

Authors:  Isabelle N King; Li Qian; Jianping Liang; Yu Huang; Joseph T C Shieh; Chulan Kwon; Deepak Srivastava
Journal:  Dev Cell       Date:  2011-04-19       Impact factor: 12.270

Review 7.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

8.  Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca(2+) currents and promote proarrhythmic behavior in ventricular myocytes.

Authors:  Worawan B Limpitikul; Ivy E Dick; Rosy Joshi-Mukherjee; Michael T Overgaard; Alfred L George; David T Yue
Journal:  J Mol Cell Cardiol       Date:  2014-05-08       Impact factor: 5.000

Review 9.  MicroRNAs: history, biogenesis, and their evolving role in animal development and disease.

Authors:  M Bhaskaran; M Mohan
Journal:  Vet Pathol       Date:  2013-09-17       Impact factor: 2.221

10.  Transcriptional regulation patterns revealed by high resolution chromatin immunoprecipitation during cardiac hypertrophy.

Authors:  Danish Sayed; Minzhen He; Zhi Yang; Lin Lin; Maha Abdellatif
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.